Short term outcome following acute phase switch among P2Y12 inhibitors in patients presenting with acute coronary syndrome treated with PCI: A systematic review and meta-analysis including 22,500 patients from 14 studies
Open Access
- 1 March 2019
- journal article
- review article
- Published by Elsevier in IJC Heart & Vasculature
- Vol. 22, 39-45
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
This publication has 26 references indexed in Scilit:
- Switching Patients from Clopidogrel to Prasugrel in Acute Coronary Syndrome: Impact of the Clopidogrel Loading Dose on Platelet ReactivityJournal of Interventional Cardiology, 2014
- Switching from high-dose clopidogrel to prasugrel in ACS patients undergoing PCI: a single-center experienceJournal of Thrombosis and Thrombolysis, 2014
- In-hospital switching of oral P2Y12 inhibitor treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Prevalence, predictors and short-term outcomeAmerican Heart Journal, 2014
- Effect on Platelet Reactivity From a Prasugrel Loading Dose After a Clopidogrel Loading Dose Compared With a Prasugrel Loading Dose AloneCirculation: Cardiovascular Interventions, 2013
- Safety of Reloading Prasugrel in Addition to Clopidogrel Loading in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary InterventionThe American Journal of Cardiology, 2013
- Switching Acute Coronary Syndrome Patients From Prasugrel to ClopidogrelJACC: Cardiovascular Interventions, 2013
- Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary SyndromesJACC, 2010
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2009
- Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 2007
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000